These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37108506)
1. Topical Application of Deglycating Enzymes as an Alternative Non-Invasive Treatment for Presbyopia. Delanghe JR; Beeckman J; Beerens K; Himpe J; Bostan N; Speeckaert MM; Notebaert M; Huizing M; Van Aken E Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108506 [TBL] [Abstract][Full Text] [Related]
2. Fructosyl Amino Oxidase as a Therapeutic Enzyme in Age-Related Macular Degeneration. Delanghe JR; Diana Di Mavungu J; Beerens K; Himpe J; Bostan N; Speeckaert MM; Vrielinck H; Vral A; Van Den Broeke C; Huizing M; Van Aken E Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732004 [TBL] [Abstract][Full Text] [Related]
3. Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation. Doki Y; Nakazawa Y; Morishita N; Endo S; Nagai N; Yamamoto N; Tamura H; Funakoshi-Tago M Mol Med Rep; 2023 May; 27(5):. PubMed ID: 36999595 [TBL] [Abstract][Full Text] [Related]
4. A Potential Role for Fructosamine-3-Kinase in Cataract Treatment. De Bruyne S; van Schie L; Himpe J; De Somer F; Everaert I; Derave W; Van den Broecke C; Huizing M; Bostan N; Speeckaert M; Callewaert N; Van Aken E; Delanghe JR Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917258 [TBL] [Abstract][Full Text] [Related]
5. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases. Babizhayev MA; Kasus-Jacobi A Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498 [TBL] [Abstract][Full Text] [Related]
6. Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia. Zamora-de La Cruz D; Zúñiga-Posselt K; Bartlett J; Gutierrez M; Abariga SA Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012648. PubMed ID: 32584432 [TBL] [Abstract][Full Text] [Related]
7. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes. Babizhayev MA; Deyev AI; Yermakova VN; Brikman IV; Bours J Drugs R D; 2004; 5(3):125-39. PubMed ID: 15139774 [TBL] [Abstract][Full Text] [Related]
9. Glycation-mediated protein crosslinking and stiffening in mouse lenses are inhibited by carboxitin in vitro. Nandi SK; Rankenberg J; Rakete S; Nahomi RB; Glomb MA; Linetsky MD; Nagaraj RH Glycoconj J; 2021 Jun; 38(3):347-359. PubMed ID: 33245448 [TBL] [Abstract][Full Text] [Related]
10. [Study of the Mechanisms of Maintaining the Transparency of the Lens and Treatment of Its Related Diseases for Making Anti-cataract and/or Anti-presbyopia Drugs]. Nakazawa Y Yakugaku Zasshi; 2020; 140(9):1095-1099. PubMed ID: 32879241 [TBL] [Abstract][Full Text] [Related]
11. UVA light-excited kynurenines oxidize ascorbate and modify lens proteins through the formation of advanced glycation end products: implications for human lens aging and cataract formation. Linetsky M; Raghavan CT; Johar K; Fan X; Monnier VM; Vasavada AR; Nagaraj RH J Biol Chem; 2014 Jun; 289(24):17111-23. PubMed ID: 24798334 [TBL] [Abstract][Full Text] [Related]
12. [Combined implantation of monofocal and multifocal intraocular lenses for presbyopia correction in cataract patients]. Mayer S; Böhm T; Häberle H; Pham DT; Wirbelauer C Klin Monbl Augenheilkd; 2008 Sep; 225(9):812-7. PubMed ID: 18759213 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological Treatments for Presbyopia. Orman B; Benozzi G Drugs Aging; 2023 Feb; 40(2):105-116. PubMed ID: 36670320 [TBL] [Abstract][Full Text] [Related]
14. Enzymatic Deglycation of Damaged Skin by Means of Combined Treatment of Fructosamine-3-Kinase and Fructosyl-Amino Acid Oxidase. De Decker I; Notebaert M; Speeckaert MM; Claes KEY; Blondeel P; Van Aken E; Van Dorpe J; De Somer F; Heintz M; Monstrey S; Delanghe JR Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240327 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatments for the correction of presbyopia. Fernández Jiménez-Ortiz H; Toledano Fernández N Arch Soc Esp Oftalmol (Engl Ed); 2024 Aug; 99(8):331-339. PubMed ID: 38663714 [TBL] [Abstract][Full Text] [Related]
16. Status of oxidative stress markers, advanced glycation index, and polyol pathway in age-related cataract subjects with and without diabetes. Chitra PS; Chaki D; Boiroju NK; Mokalla TR; Gadde AK; Agraharam SG; Reddy GB Exp Eye Res; 2020 Nov; 200():108230. PubMed ID: 32931824 [TBL] [Abstract][Full Text] [Related]
17. Sequential Application of Glass Coverslips to Assess the Compressive Stiffness of the Mouse Lens: Strain and Morphometric Analyses. Cheng C; Gokhin DS; Nowak RB; Fowler VM J Vis Exp; 2016 May; (111):. PubMed ID: 27166880 [TBL] [Abstract][Full Text] [Related]
18. Aggrelyte-2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia. Panja S; Nahomi RB; Rankenberg J; Michel CR; Gaikwad H; Nam MH; Nagaraj RH Aging Cell; 2023 Apr; 22(4):e13797. PubMed ID: 36823285 [TBL] [Abstract][Full Text] [Related]
19. [Aging of the crystalline lens and presbyopia]. Beers AP; van der Heijde GL; Dubbelman M Tijdschr Gerontol Geriatr; 1998 Aug; 29(4):185-8. PubMed ID: 9746933 [TBL] [Abstract][Full Text] [Related]
20. Rate of formation of AGEs during ascorbate glycation and during aging in human lens tissue. Cheng R; Lin B; Ortwerth BJ Biochim Biophys Acta; 2002 May; 1587(1):65-74. PubMed ID: 12009426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]